Assessment of adherence to antiviral therapy in HIV-infected children using the medication event monitoring system, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping

Journal of Acquired Immune Deficiency Syndromes

Volumn 33, Issue 2, 2003, Pages 211-218

  Farley, John ^a   Hines, Susan ^a   Musk, Amy ^a   Ferrus, Sherley ^a   Tepper, Vicki ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Adherence; Children; Electronic monitoring; HIV 1

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CAREGIVER; CHILD; CHILD HEALTH CARE; CLINICAL ARTICLE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NURSE; PATIENT COMPLIANCE; PATIENT MONITORING; PHARMACY; PHYSICIAN; PRIORITY JOURNAL; SELF REPORT; VIRUS INFECTION; VIRUS LOAD;

EID: 0038417192     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200306010-00016     Document Type: Article

References (23)

1. Gortmaker SL, Hughes M, Cervia J, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV. N Engl J Med. 2001;345:1522-1528.
2. Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR Morb Mortal Wkly Rep. 1998;47(RR-4):1-31.
3. Watson DC, Farley JJ. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J. 1999;18:682-689.
4. Reddington C, Cohen J, Baldillo A, et al. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr Infect Dis J. 2000;19:1148-1153.
5. Waterhouse DM, Calzone KA, Mele C, et al. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol. 1993;11:1189-1197.
6. Lee JY, Kusek JW, Greene PG, et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) pilot study. Am J Hypertens. 1996;9:719-725.
7. Vanhove GF, Schapiro JM, Winters MA, et al. Patient compliance and drug failure in protease inhibitor monotherapy. JAMA. 1996; 276:1955-1956.
8. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134:968-977.
9. Brown L, Sherbenou RJ, Johnsen SK. Test of nonverbal intelligence. A language free measure of cognitive ability. 2nd ed. Austin: Pro-Ed, 1990.
10. Paterson DL, Swindles S, Mohr JA, et al. Adherence with protease inhibitor therapy for human immunodeficiency virus infection [abstract]. Presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 1998. Washington, DC: American Society for Microbiology, 1998.
11. Maeland A, Holberg M, Bruuni JN, et al. Subtle difference in low-level HIV viral load on treatment is important for outcome [abstract]. Presented at the Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, February 1998. Alexandria, VA: Foundation for Retrovirology and Human Health, 1998.
12. Yogev R, Stanley SA, Nachman S, et al. Virologic efficacy of ZDV+3TC vs d4T+ritonavir (RTV) vs ZDV+3TC+RTV in stable antiretroviral experienced HIV-infected children (Pediatric ACTG Trial 338) [abstract]. Presented at the Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, February 1998. Alexandria, VA: Foundation for Retrovirology and Human Health, 1998.
13. 3 [abstract]. In: Programs and Abstracts of the Eighth Congress of Clinical Microbiology and Infectious Diseases, Lausanne, May 1997.
14. Kaplan A, Golin C, Beck K, et al. Adherence to protease inhibitor therapy and viral load [abstract]. Presented at the Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, January-February 1999. Alexandria, VA: Foundation for Retrovirology and Human Health, 1999.
15. Gordis L, Markowitz M, Lilienfield AM. The inaccuracy in using interview to estimate patient reliability in taking medications at home. Med Care. 1969;17:49-54.
16. Steele RG, Anderson B, Rindel B, et al. Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs. AIDS Care. 2001;13:617-629.
17. Van Dyke RB, Lee S, Johnson GM, et al. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics. 2002;109:e61.
18. Charney E, Bynum R, Eldredge D, et al. How well do patients take oral penicillin? A collaborative study in private practice. Pediatrics. 1967;40:188-195.
19. Wood HF, Feinstein AR, Taranta A, et al. Rheumatic fever in children and adolescents: a long-term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae. Ann Intern Med. 1964;60(Suppl):31-46.
20. Caron HS, Roth HP. Patient's cooperation with a medical regimen. JAMA. 1968;203:922-926.
21. Davis MS. Variations in patients' compliance with doctors' orders: analysis of congruence between survey responses and results of empirical investigations. J Med Educ. 1966;41:1037-1048.
22. Mushlin AI, Appel FA. Diagnosing potential noncompliance: physician's ability in a behavioral dimension of medical care. Arch Intern Med. 1977;137:318.
23. Bangsberg DR, Hecht FM, Clague H, et al. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;26:435-442.